Infinity Pharmaceuticals reported $14.34M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Amgen AMGN:US $ 12618M 268M
AstraZeneca AZN:LN 1791796.84M 60282.28M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Cytori Therapeutics CYTX:US $ 6.97M 2.05M
Eisai 4523:JP Y 301894M 11439M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Infinity Pharmaceuticals INFI:US $ 14.34M 0.94M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Novartis NOVN:VX SF 27646M 2161M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Vascular Biogenics VBLT:US 8.81M 2.24M
YTE INCY:US $ 926.67M 40.51M